Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications considerations characterizing real‐world data relevance quality regulatory purposes
… An alternative method for estimating societal costs when data are lacking Potential other benefits and contextual considerations: Terminology updates to “Benefits Beyond … obtain data on hours lost by the disease, health-related quality of life impact, burden of disease for different …
… Urticaria OPPORTUNITY Our client wanted to measure real-world treatment patterns, healthcare resource use, HRQOL, and … with chronic idiopathic urticaria (CIU). They needed this data to understand the natural history of the disease and …
… ISPE will address in the next few years. At a time when real-world data is gaining visibility among non-pharmacoepidemiologists, …
… and development of all study-specific documents, site and data management, data analysis, literature reviews, and … projects as a Senior Clinical Project Coordinator in the Real World Late Phase Department at Quintiles. She has more than 5 …
… expected by 2025 or 2026, aims to shorten the period of regulatory protection. However, it incentivizes the … they may face in drug development as they move toward regulatory approval and market access in the US and EU. They … closely align their strategies for clinical development, regulatory processes, market access, and pricing. Integrated …
… it is important to generate clinical evidence to support regulatory success, but also to generate evidence on … who are new to or unfamiliar with the increasing use and relevance of market access and economic evidence generation …
… fit-for-purpose healthcare policy, provision, outcomes, data, and systems studies in partnership with a diversity of … to support pharmaceutical development, explorative real-world data studies in pediatric neurodegenerative disease, …
… early-stage non-small cell lung cancer (NSCLC): a global real-world study. Lin SH, Kahangire DA, Nagar S , Ahn M, Affi R, …
… administered online brought improvements to access and quality of research. With the rise in use of mobile computing … a respondent’s device adversely affect choice behavior or data quality?” The differences between PC and mobile device experiences are well known. While data collection software can be optimized for each …
… expected by 2025 or 2026, aims to shorten the period of regulatory protection. However, it incentivises the … they may face in drug development as they move toward regulatory approval and market access in the US and EU. They … closely align their strategies for clinical development, regulatory processes, market access, and pricing. Integrated …